Remasog, Johaina .

HRN: 29-08-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2026
MUPIROCIN 2%, 15G (TUBE)
06/11/2026
06/17/2026
TOPICAL
2%
BID
Infected Post-CTT Site
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: